Conrad P Quinn Selected Research

Anthrax

12/2019	Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019.
1/2018	Validated MALDI-TOF-MS method for anthrax lethal factor provides early diagnosis and evaluation of therapeutics.
1/2018	Galactosylation of the Secondary Cell Wall Polysaccharide of Bacillus anthracis and Its Contribution to Anthrax Pathogenesis.
1/2016	Recent developments in the understanding and use of anthrax vaccine adsorbed: achieving more with less.
1/2016	Anthrax Toxin-Expressing Bacillus cereus Isolated from an Anthrax-Like Eschar.
11/2015	Antitoxin Treatment of Inhalation Anthrax: A Systematic Review.
6/2014	Detection of anthrax protective antigen (PA) using europium labeled anti-PA monoclonal antibody and time-resolved fluorescence.
2/2014	Lethal factor and anti-protective antigen IgG levels associated with inhalation anthrax, Minnesota, USA.
3/2013	Quantitative assessment of anthrax vaccine immunogenicity using the dried blood spot matrix.
9/2012	Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Conrad P Quinn Research Topics

Disease

24	Anthrax 12/2019 - 10/2002
11	Inhalation anthrax 05/2019 - 10/2004
7	Infections 01/2017 - 01/2004
3	Toxemia 05/2019 - 11/2011
3	Edema (Dropsy) 03/2011 - 06/2009
2	Cutaneous anthrax 11/2011 - 10/2004
2	Pain (Aches) 03/2004 - 09/2002
1	Whooping Cough (Pertussis) 01/2019
1	Soft Tissue Infections 01/2017
1	Pneumonia (Pneumonitis) 07/2011
1	Inflammation (Inflammations) 03/2011
1	Bacteremia 08/2009
1	Disease Progression 04/2007

Drug/Important Bio-Agent (IBA)

15	AntigensIBA 01/2019 - 10/2004
11	Immunoglobulin G (IgG)IBA 11/2014 - 01/2004
9	Anthrax Vaccines (Vaccines, Anthrax)IBA 12/2019 - 05/2006
9	anthrax toxin (anthrax lethal factor)IBA 01/2018 - 10/2004
6	VaccinesIBA 01/2019 - 12/2006
5	Immunoglobulins (Immunoglobulin)IBA 06/2014 - 10/2004
3	AntitoxinsIBA 12/2019 - 11/2011
3	edema factorIBA 05/2019 - 06/2009
3	AntibodiesIBA 01/2019 - 01/2004
3	Polysaccharides (Glycans)IBA 01/2018 - 07/2011
3	ZincIBA 01/2018 - 11/2007
3	TrisaccharidesIBA 01/2018 - 05/2011
3	Monoclonal AntibodiesIBA 01/2017 - 11/2007
3	EnzymesIBA 03/2013 - 01/2004
3	ImmunosorbentsIBA 03/2013 - 01/2004
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2004
2	Virulence Factors (Pathogenicity Factors)IBA 01/2018 - 06/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2015 - 10/2005
2	EndopeptidasesIBA 03/2004 - 09/2002
2	Neurotransmitter Agents (Neurotransmitter)IBA 03/2004 - 09/2002
1	pertactin FDA Link 01/2019
1	Hemagglutinins (Hemagglutinin)IBA 01/2019
1	Adenylate Cyclase ToxinIBA 01/2019
1	Pertussis ToxinIBA 01/2019
1	Anthrax Immune Globulin IntravenousIBA 01/2017
1	antineoplaston A10 (A 10)IBA 01/2017
1	BiothraxIBA 07/2015
1	AS 8IBA 04/2015
1	4,6- dideoxy- 4- (3- hydroxy- 3- methylbutanamido)- 2- O- methylglucopyranoseIBA 05/2011
1	CarbohydratesIBA 05/2011
1	Proteins (Proteins, Gene)FDA Link 03/2011
1	ExotoxinsIBA 11/2010
1	Prostaglandins AIBA 08/2009
1	Glutamic Acid (Glutamate)FDA Link 08/2009
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 06/2009
1	Bacterial AntigensIBA 03/2008
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2007
1	OligosaccharidesIBA 12/2006
1	Analgesics (Analgesic Drugs)IBA 03/2004
1	erythrina lectinIBA 03/2004
1	NeurotoxinsIBA 09/2002

Therapy/Procedure

4	Therapeutics 01/2018 - 11/2007
2	Microspheres (Microsphere) 01/2019 - 01/2004
1	Injections 07/2015
1	Intramuscular Injections 11/2012
1	Euthanasia (Mercy Killing) 08/2009
1	Immunotherapy 04/2008
1	Chemoprevention 10/2002